Inihahanda pa ang salin na ito. Samantala, pansamantala naming ipinapakita ang orihinal na bersiyong Ingles.
Mga pahayag ng kumpanya · 11/13/20261 min read
Leqembi® Pen subcutaneous treatment launched in Japan
Lokal na awtomatikong pagsasalin · Orihinal na wika ng pinagmulan
Buod
STOCKHOLM, Nov. 13, 2026 — BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been launched in Japan for the…
Orihinal na wika ng pinagmulan: PR Newswire UK — News ReleasesBuksan ang orihinal na pahayag →